The distribution and properties of neutral peptidases acting on the peptide hormone bradykinin (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg) were determined in several rabbit tissues. The supernatant and particulate fractions prepared from tissue homogenates (250OOg for 60min) were studied. Bradykinin inactivation (kininase activity) was measured by bioassay with the isolated guinea-pig ileum. The sites of peptide-bond cleavage were determined in the amino acid analyser, which permits detection and measurement of amino acids and peptides derived from bradykinin. The results indicate that kininases are present in a wide range of concentrations in different tissues, kidney and lung having the most activity. Kininases present in different tissues were distinguished on the basis of sensitivity to the effects of EDTA, dithiothreitol and ZnCl2 and by the site of peptide-bond hydrolysis in bradykinin.
The distribution and properties of neutral peptidases acting on the peptide hormone bradykinin (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg) were determined in several rabbit tissues. The supernatant and particulate fractions prepared from tissue homogenates (250OOg for 60min) were studied. Bradykinin inactivation (kininase activity) was measured by bioassay with the isolated guinea-pig ileum. The sites of peptide-bond cleavage were determined in the amino acid analyser, which permits detection and measurement of amino acids and peptides derived from bradykinin. The results indicate that kininases are present in a wide range of concentrations in different tissues, kidney and lung having the most activity. Kininases present in different tissues were distinguished on the basis of sensitivity to the effects of EDTA, dithiothreitol and ZnCl2 and by the site of peptide-bond hydrolysis in bradykinin.
The study of the number, distribution and properties of tissue peptidases active at physiological pH represents a necessary approach to the determination of the enzymes involved in protein turnover and activation and inactivation of enzymes and peptide hormones (Schimke & Bradley, 1975) . We have attempted to determine whether several tissues from rabbit contain the same or different classes of peptidases capable of hydrolysing bradykinin (Arg1-Pro2-Pro3 -Gly4 -Phe5 -Ser6 -Pro7 -Phe8 -Arg9). Similar studies have been performed by Rapley et al. (1971) using di-, tri-or tetra-peptides as substrates for enzymes from human tissues. They concluded that the same peptidases exist in the tissues studied, but that they are present in awiderange ofconcentrations.
The combination of the bioassay method, which measures the loss of biological activity when any peptide bond of bradykinin is hydrolysed, and an analytical chromatographic procedure for the identification of bradykinin peptide fragments was used to detect kininase activity and to identify the sites of peptide-bond hydrolysis. The results reported here indicate that the enzymes which are responsible for the inactivation of bradykinin in homogenates of several tissues exhibit different properties. These properties include the activation or inhibition by several compounds and the site of peptide-bond hydrolysis in bradykinin.
Experimental
Materials Aminex A-5 and A-6 resins were purchased from Bio-Rad Laboratories, Richmond, CA, U.S.A.
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Bradykinin and the other synthetic peptides used in this study were synthetized by Dr. A. C. M. Paiva (Escola Paulista de Medicina, Sao Paulo, Brazil). The peptides had integral molar ratios of constituent amino acids after acid hydrolysis and were homogeneous by high-voltage electrophoresis at pH3.5.
Methods
Enzyme preparation. Mature rabbits were anaesthetized with pentobarbital (40mg/kg body wt.) and both carotid arteries were cannulated. After the jugular veins were excised, cold 0.9% NaCl solution was infused to eliminate blood. The tissues (liver, brain, spleen, kidney, lung, heart, skeletal muscle and ileum) were rapidly removed from the animal and transferred to cold 0.9% NaCl solution. The smooth muscle was obtained from the ileum. The tissues were cut into small pieces, washed several times with cold 0.9% NaCl solution and homogenized with a Potter-Elvehjem homogenizer in 7vol. (v/w) of0.25M-sucrose/0.01 M-Tris/HCI, pH 7.5. The homogenates were centrifuged at 25000g for 1 h at 4°C. The precipitate was suspended in 5vol. of 0.25M-sucrose/0.01M-Tris/HCI, pH7.5. Blood was collected into heparin from an anaesthetized animal by cardiac puncture and centrifuged at 750g for 1 h at 4°C. Samples (2ml each) of particulate material (p) (i.e. pellet after centrifugation), supernatant (s) and also plasma were dialysed against 700vol. of 0.1 M-sodium phosphate buffer, pH7.5 at 4°C. The buffer was replaced twice at 4h intervals. These preparations, which constitute the source of tissue p kininases, were kept at -20°C and used within 20 days.
Determination of bradykinin inactivation:kininase assay. A bioassay with the isolated guinea-pig ileum was used to measure the concentration of bradykinin. The response, the extent ofcontraction ofthe smooth muscle, was standardized with known amounts of the hormone. The kininase assay consists of the determinations of residual bradykinin activity by matching the response of the test solution with that of the control . The isolated guinea-pig ileum was bathed at 37°C in lOml of Tyrode buffer (0.138M-NaCI/18,uM-CaCI2/2.68 mm-KCI / 0.49mM-MgCI2 / llmM-NaHCO3 / 0.36mr-NaH2PO4) containing 0.35M-atropine, 1.7M-diphenylhydramine and 2.8mM-glucose.
Bradykinin (5-80nmol) was incubated at 37°C with enzyme in 0.05M-sodium phosphate buffer, pH7.5, containing 0.1 M-NaCl. The concentration of enzyme was selected so as to give 40-60% inactivation within 18min. Residual bradykinin was determined after 6, 12 and 18min of incubation. The rate of reaction was essentially linear with time in the range studied. All determinations were carried out in duplicate.
Determination of the effect of various compounds on kininase activity. EDTA, dithiothreitol, peptide BPPga(<Glu-Trp-Pro-Pro-Arg-Pro-Gln-Ile-Pro-Pro) and ZnCl2 were incubated with the dialysed tissue fractions for 10min at 0°C at the concentration given in the legend to Table 1 , and the kininase activity was determined by bioassay. A separate control tube containing bradykinin and compound, but no enzyme, was used as reference to correct for the effect of the compound on the response of the guinea-pig ileum to bradykinin. The only compound for which this correction was necessary was peptide BPP9a, which potentiates the activity of bradykinin on the isolated guinea-pig ileum .
Determination ofpeptides and amino acids derived from bradykinin. An automatic amino acid analyser (Alonzo & Hirs, 1968 ) was operated as previously described (Camargo et al., 1973) . Samples were analysed by the two-column system of Spackman et al. (1958) with the buffer systems described by Oliveira et al. (1976) . The short-column (Aminex A-5 resin) system permits the detection and determination ofthe following peptides: Arg-Pro-Pro-Gly, Arg-Pro-Pro-Gly-Phe, Arg-Pro-Pro-Gly-Phe-Ser, Arg-Pro-Pro-Gly-Phe-Ser-Pro, Phe-Ser-Pro-Phe-Arg, Ser-Pro-Phe-Arg and Phe-Arg. Des-Arg1-Pro2-bradykinin and Pro-Phe-Arg were the only basic peptides that could not be detected with this system. Arg-ProPro was not completely separated from Arg-Pro-ProGly-Phe-Ser-Pro, and the peaks of Ser-Pro-Phe-Arg and des-Arg9-bradykinin overlapped. When both peptides were present, determination was not possible. However, it was possible to detect the presence of one peptide mixed with the other by the A570/A440 ratio. The ratios were: Arg-Pro-Pro, 1.5; Arg-ProPro-Gly-Phe-Ser-Pro, 3.6; Ser-Pro-Phe-Arg, 4.9; des-Arg9-bradykinin, 1.8. The long column (Aminex A-6 resin) was used to detect acidic or neutral free amino acids and Ser-Pro. The relative colour yields (area/concentration) and the chromatographic behaviour of the synthetic peptides are described in Oliveira et al. (1976) .
Protein determination. Protein was determined by the method of Lowry et al. (1951) with crystalline bovine serum albumin as standard.
Results

Kininase activity in tissue homogenates
Kininase activity was determined for the two fractions prepared from the homogenate of each tissue by a single centrifugation procedure where most of the sedimentable particles (p) were separated from the soluble fraction (s). The activity of each fraction was measured at two substrate concentrations. The rates of bradykinin inactivation obtained with low substrate concentration (5M) were not less than one-half those obtained with a substrate concentration 16 times higher for all fractions studied, except liver supernatant. The results in Table 1 indicate that the specific activities (per mg of protein or per g wet wt.) for kidney and lung (both s and p fractions) were about 160 and 1200 times greater respectively than that of plasma, which had the lowest specific activity. The activity present in lung and kidney was several times greater than that found in the other tissues studied. The amount of kininase activity was equally distributed in the s and p fractions, or was predominantly in the s fraction, in all tissues except for kidney, where most of the activity was recovered in the p fraction.
Susceptibility oftissue kininases to various compounds
The kininase response to the effect of various inhibitors or activators was compared by using compounds selected on the basis of their effect on kininases described in the literature (Erd6s & Yang, 1970; Camargo et al., 1973) . Table 2 demonstrates that the effects of inhibitors and activators are different on kininases from the different tissues. Two groups of tissue kininases can be distinguished on the basis of the EDTA effect and then further classified with respect to sensitivity to dithiothreitol and ZnCl2.
Group I: EDTA-sensitive kininases. Kininases from lung (s and p), liver (s and p), plasma, skeletal muscle (p) and smooth muscle (p) were completely inhibited by 1 mM-EDTA, whereas kininases from heart and spleen (s and p) and from smooth muscle (s) and kidney (p) were only partially inhibited by lmm-EDTA. The kininases present in both the super-1977 Fig. 1 . Hydrolysis of Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg (bradykinin) by supernatant fractions derived from rabbit tissue homogenates The values indicated by the width of the bars are nmol of the peptide or free aniino acids recovered after approx. 50°/ hydrolysis of bradykinin. The enzymic hydrolysates were prepared as follows: bradykinin (80nmol) was incubated in l.0ml of 0.05M-sodium phosphate buffer (pH7.5)/O.lM-NaCI at 35°C with tissue-supernatant fractions. The extent of hydrolysis of bradykinin was determined by bioassay. After 50% of the bradykinin had been hydrolysed, the reaction was stopped by the addition of 1.2ml of a 30% (v/v) solution of poly(ethylene glycol) in 0.32M-sodium citrate buffer containing 0.05 M-HCI. The hydrolysis products were determined by chromatographic analysis (see under 'Methods').
Sites ofpeptide-bond hydrolysis in bradykinin by tissue peptidases
Figs. I and 2 show the pattern ofproducts obtained from bradykinin when 50 % of the hormone had been inactivated by enzymes from tissue supernatant and particulate fractions respectively. The products of bradykinin degradation recovered in these experiments account for 60-80% of the peptide hydrolysed. Arginine and phenylalanine in approximately equal concentrations were the major products. The amount of glycine, proline and serine recovered (not shown in Figs. 1 and 2 ) was equivalent to 10-20% of the arginine in most of the incubation mixtures. There are, however, large differences in the peptide products of bradykinin. The complementary peptides Arg-ProPro-Gly-Phe-Ser-Pro and Phe8-Arg9 were released in higher quantities by kidney, lung and smooth muscle than by the other tissues. On the other hand, two other complementary peptides, Arg-Pro-ProGly-Phe and Ser-Pro-Phe-Arg, were recovered in higher amounts in hydrolysate containing enzymes from brain (s and p), heart (s and p), liver (p) and spleen (p).
The detailed interpretation of these patterns of products requires knowledge of the specificity and properties of the enzymes. This is possible for the kininase activity of plasma (Fig. 1) , which can be interpreted in terms of kinase I and II, which have been characterized by Erdos and collaborators (Erdos & Sloane, 1962; Yang et al., 1971) . Kininase I (EC 3.4.12.8) is carboxypeptidase N, which hydrolyses the Phe8-Arg9 peptide bond. Kininase II, peptidyl dipeptidase (EC 3.4.15.1) hydrolyses the Pro7-Phe8 bond of bradykinin. All of the expected products, Arg-Pro-Pro-Gly-Phe-Ser-Pro, Phe8-Arg9, free arginine and Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe, were detected, and all but the octapeptide were determined quantitatively. The presence of free arginine and free phenylalanine is probably due to hydrolysis of the Phe-Arg dipeptide, and the small excess of arginine relative to phenylalanine most likely reflects the activity of kininase I (carboxypeptidase N). Thus it is possible to rationalize the products that were recovered in terms of characterized kininases of plasma. It should be emphasized that no other peptide fragments were in fact detected. Although detailed interpretation of the patterns obtained with other tissues is more complicated, it is clear that the patterns of products obtained are different for each tissue (see the Discussion section).
Discussion
The bioassay method used to measure kininase activity is based on the loss of smooth-musclecontracting activity of bradykinin. Since the hydrolysis of any peptide bond in bradykinin abolishes biological activity (Suzuki et al., 1969) at the concentrations used in our assay, it is reasonable to expect that a variety of tissue peptidases could inactivate bradykinin. Some fragments of bradykinin at concentrations orders of magnitude higher than used in the assay do have some smooth-musclecontracting activity. The ability of several tissues to inactivate bradykinin at pH7.5 and the properties of this class of neutral peptidases were studied to determine if similarities and/or differences exist among rabbit tissues. As a first approach to this problem, we studied the total kininase activity present in the tissues instead of using purified preparations, to avoid losses of enzymes during the purification procedure. Although the study of the mixture of enzymes present in the tissue homogenate does not Vol. 163 permit conclusions on the number and characteristics of the individual enzymes, it does allow the comparison of properties of the kinetically predominant kininases present in the tissues.
The relative capacity of tissue homogenates to inactivate bradykinin (calculated as specific activity relative to weight of tissue or protein content) varied over a 1200-fold range with kidney having the highest and plasma the lowest values. Differences of 2-fold in the initial rate of hydrolysis, which was linear with time up to 50% inactivation of bradykinin, were observed when substrate was 5 or 80AuM. The rate of hydrolysis was higher at the higher substrate concentration in 15 out of 17 fractions studied. The factor of 2 in the initial rate is very small compared with the large differences observed between some tissues. Differences in content and specific activity have been demonstrated for angiotensin-converting enzyme among the tissues of rat (Cushman & Cheung, 1971) and also in several common laboratory animals (Cushman & Cheung, 1972) . These differences for angiotensin-converting enzyme in the rat were smaller than we have observed for kininase in the rabbit, and the ranking of the tissues in terms of specific activity does not correspond.
The data demonstrate that the most active kininases present in each tissue can be readily distinguished on the basis of their sensitivity to EDTA, ZnC2 anld dithiothreitol. For some tissues, these differences are quite striking. For example, 1 mM-EDTA completely inhibits kininase activity in lung (s and p), liver (s and p) and plasma, but it does not affect kininase activity in brain (s and p). Large differences in sensitivity to EDTA were also detected between the supernatant and particulate fractions prepared from kidney, heart and skeletal muscle. The differences in the pattern of peptide products obtained for kininase activity, though less direct than the enzyme-inhibitor studies, provides a second type of evidence, which indicates the presence of different peptidases in the tissues studied. The analysis of the products generated by the plasma enzymes is consistent with the presence of kininases I and II, described in the literature (Erdos & Sloane, 1962; Yang et al., 1971 ) (see the Results section). Similarly, the products released by brain enzymes are consistent with the specificity of kininases A and B, which hydrolyse the Phe5-Ser6 and Pro7-Phe8 bonds respectively (Oliveira et al., 1976) . However, additional dipeptidases must be invoked to account for the free amino acids detected (Smith, 1960; Campbell et al., 1966; Hayman & Patterson, 1971) . The recovery of the complementary peptides Arg-Pro-Pro-Gly-Phe and Ser-Pro-Phe-Arg, as well as Arg-Pro-Pro-GlyPhe-Ser-Pro and Phe8-Arg9, suggest that enzymes with specificity similar to brain kininase A and B exist also in other tissues such as heart (s and p) and skeletal muscle (s). However, hydrolysis of the same peptide bond does not necessarily indicate that the enzymes are identical. For example, both brain kininase B and angiotensin-converting enzyme (peptidyl dipeptidase, EC 3.4.15.1) hydrolyse bradykinin only at the Pro7-Phe8 peptide bond. Kininase B inactivates both angiotensin I and II (C. Spadaro, unpublished work), whereas the converting enzyme transforms angiotensin I into angiotensin II and does not act on angiotensin II. Experiments with doublelabelled peptides or more detailed kinetic studies would be required to demonstrate that the complementary fragments are derived from the same molecule.
The kininases may be part of the intracellular machinery for protein breakdown, or may participate in the metabolism of peptide hormones, or both. It is difficult to interpret the large differences in activity among the tissues or to relate the multiplicity of kininases to a physiological function. The isoenzymes of lactate dehydrogenase (Wilkinson, 1970) , hexokinase (Katzen, 1967) and esterase (Coates et al., 1975) illustrate one type of selective distribution of enzymes that act on the same substrate. It has been possible to establish a relationship between the metabolic role of the tissue and the isoenzyme tissue distribution in terms of specificity for alternative substrates and the effect of hormones and inhibitors on enzyme activity (see Wilkinson, 1970) . If the kininases are not isoenzymes, then the multiplicity would seem to indicate that the tissues do not share a common proteolytic system to degrade the nonapeptide bradykinin unless the localization of an enzyme makes its contribution the most significant. This may be true for circulating kinins, which are hydrolysed by the dipeptidyl carboxypeptidase located on the membrane of the endothelial cell of the vascular bed (Ryan et al., 1975; Caldwell et al., 1976) .
